Elias A. Rahal

Publications

• Editorial: The Microbial Modulation of Autoimmune Processes and Proinflammatory Pathways
  Frontiers in Cellular and Infection Microbiology. 2022  |   Pubmed ID: 35982782
• Methods for Fighting Emerging Pathogens
  Nature Methods. 04, 2022  |   Pubmed ID: 35396474
• IL-17A in COVID-19 Cases: a Meta-analysis
  Journal of Infection in Developing Countries. 11, 2021  |   Pubmed ID: 34898490
• Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease
  Viruses. 06, 2021  |   Pubmed ID: 34210024
• Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model
  Frontiers in Immunology. 2021  |   Pubmed ID: 34040613
• As a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases
  Frontiers in Immunology. 2021  |   Pubmed ID: 33828545
• Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
  Frontiers in Oncology. 2020  |   Pubmed ID: 32596146
• Atorvastatin Increases the Production of Proinflammatory Cytokines and Decreases the Survival of Escherichia Coli-infected Mice
  Scientific Reports. 08, 2019  |   Pubmed ID: 31406240
• Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice
  Journal of Virology. 10, 2019  |   Pubmed ID: 31375581
• The Role of Viral Infections in the Development of Autoimmune Diseases
  Critical Reviews in Microbiology. Aug, 2019  |   Pubmed ID: 31145640
• Endosomal Toll-Like Receptors (TLRs) Mediate Enhancement of IL-17A Production Triggered by Epstein-Barr Virus (EBV) DNA in Mice
  Journal of Infection in Developing Countries. Feb, 2018  |   Pubmed ID: 31805001
• Epstein-Barr Virus DNA Modulates Regulatory T-cell Programming in Addition to Enhancing Interleukin-17A Production Via Toll-like Receptor 9
  PloS One. 2018  |   Pubmed ID: 29995930
• Epstein-Barr Virus DNA Enhances Diptericin Expression and Increases Hemocyte Numbers in Via the Immune Deficiency Pathway
  Frontiers in Microbiology. 2018  |   Pubmed ID: 29942298
• Atorvastatin Reduces the Survival of Candida Albicans-Infected BALB/c Mice
  Frontiers in Microbiology. 2015  |   Pubmed ID: 26732740
• Epstein-Barr Virus and Human Herpes Virus 6 Type A DNA Enhance IL-17 Production in Mice
  Viral Immunology. Jun, 2015  |   Pubmed ID: 25870901
• Approaches to Treatment of Emerging Shiga Toxin-producing Escherichia Coli Infections Highlighting the O104:H4 Serotype
  Frontiers in Cellular and Infection Microbiology. 2015  |   Pubmed ID: 25853096
• Effect of Rifampicin and Gentamicin on Shiga Toxin 2 Expression Level and the SOS Response in Escherichia Coli O104:H4
  Foodborne Pathogens and Disease. Jan, 2015  |   Pubmed ID: 25383748
• Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia Coli O157:H7 Shiga Toxin Release and Role of the SOS Response
  Foodborne Pathogens and Disease. Sep, 2013  |   Pubmed ID: 23808851
• Escherichia Coli O157:H7-Clinical Aspects and Novel Treatment Approaches
  Frontiers in Cellular and Infection Microbiology. 2012  |   Pubmed ID: 23162800
• The Impact of Prophylactic Antiviral Agents and Statin Administration on Graft Longevity in Kidney Allograft Recipients
  Immunopharmacology and Immunotoxicology. Oct, 2012  |   Pubmed ID: 22292901
• Decrease in Shiga Toxin Expression Using a Minimal Inhibitory Concentration of Rifampicin Followed by Bactericidal Gentamicin Treatment Enhances Survival of Escherichia Coli O157:H7-infected BALB/c Mice
  Annals of Clinical Microbiology and Antimicrobials. Sep, 2011  |   Pubmed ID: 21906403
• Role of Rifampicin in Limiting Escherichia Coli O157:H7 Shiga-like Toxin Expression and Enhancement of Survival of Infected BALB/c Mice
  International Journal of Antimicrobial Agents. Feb, 2011  |   Pubmed ID: 21129928